Ethos unveils new sample collection kit for Covid-19 antibody test

Ethos Laboratories has launched the new fingertip blood collection kit, Tru-Immune, for its Covid-19 neutralizing antibody test.

The kit provides quantitative data regarding the viral blocking efficacy of neutralizing antibodies.

Individuals can use the kit to measure their current immunity levels against Covid-19 safely, quickly and efficiently in real time with less pain.

Additionally, it will help people monitor their neutralizing antibody levels and reduce the risk of infection.

The Tru-Immune uses a single drop of capillary blood from the patient’s fingertip, which will be returned to Ethos via prepaid, priority postage. It delivers the results electronically within 48 hours.

Ethos Laboratories CEO Brian Kincaid said: “As we enter the third year of the global Covid-19 pandemic, the question is no longer, ‘Do I have Covid-19 antibodies? Instead, people ask, “What level of protective immunity do I have against future infection and do I need a booster shot?” These questions can now be answered with Tru-Immune.

Content from our partners
Precision Thread: The Future of Customized Medical Treatment
Why this global life sciences COO thinks relocating to Charleston, SC, was key to achieving next-level success

Covid-19 neutralizing antibody tests will provide information on levels of immunity to the disease in the individual.

This will help the healthcare provider make decisions about vaccination and booster schedules.

Ethos noted that neutralizing antibody tests like Tru-Immune should become the test of choice for recording natural immunity in states, where employers need evidence to obtain exemption from vaccine mandates.

In April, Ethos introduced a new molecular test to detect major SARS-CoV-2 virus strains, including variants from UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1).

Related companies

Comments are closed.